Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to characterize the effects of low doses of LSD (d-lysergic acid diethylamide) on behavioral and neural indicators of feedback and feedforward signaling in perceptual decision-making.


Clinical Trial Description

The study team will subject healthy participants to multiple perceptual decision-making tasks after the administration of low doses of LSD (d-lysergic acid diethylamide) as a pharmacological challenge. The investigators want to illuminate the behavioral and neural effects of psychedelics on prior beliefs and evidence processing. Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Subjects will be under continuous supervision until approximately 4.5h after substance administration. The participants are asked to perform the following cognitive tasks alongside EEG measurement after administration of either LSD or placebo: Changepoint task, history bias task, surround suppression task, auditory steady-state response paradigm, motor localizer task. ;


Study Design


NCT number NCT05976698
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact Philipp Sterzer, Prof. Dr.
Phone +41 61 325 81 55
Email philipp.sterzer@upk.ch
Status Recruiting
Phase N/A
Start date February 20, 2024
Completion date September 2024